Qube Research & Technologies (QRT)’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-171,972
Closed -$5.45M 4145
2025
Q4
$5.45M Sell
171,972
-400,463
-70% -$12.5M 0.01% 1716
2025
Q3
$16.1M Buy
572,435
+241,254
+73% +$7.31M 0.02% 1015
2025
Q2
$12.2M Buy
331,181
+91,783
+38% +$3.17M 0.01% 1167
2025
Q1
$9.4M Buy
239,398
+19,467
+9% +$877K 0.01% 1179
2024
Q4
$10.2M Buy
219,931
+29,117
+15% +$1.32M 0.01% 1073
2024
Q3
$8.62M Buy
190,814
+183,084
+2,368% +$8.71M 0.01% 1121
2024
Q2
$381K Sell
7,730
-7,046
-48% -$287K ﹤0.01% 2227
2024
Q1
$507K Buy
+14,776
New +$533K ﹤0.01% 2525
2023
Q2
Sell
-106,993
Closed -$1.61M 3033
2023
Q1
$1.61M Buy
+106,993
New +$2.36M 0.01% 1104
2022
Q4
Sell
-47,072
Closed -$1.66M 3012
2022
Q3
$1.66M Buy
+47,072
New +$2M 0.01% 1013
2022
Q2
Sell
-11,279
Closed -$557K 3139
2022
Q1
$557K Buy
+11,279
New +$625K ﹤0.01% 1482
2021
Q4
Sell
-7,774
Closed -$832K 2980
2021
Q3
$832K Buy
+7,774
New +$890K 0.01% 972
2021
Q2
Sell
-4,409
Closed -$546K 2807
2021
Q1
$546K Buy
+4,409
New +$670K 0.01% 1126

Other funds holding TWST

Qube Research & Technologies (QRT)'s TWST Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Twist Bioscience (TWST) in Q1 2026, closing a stake of 171,972 shares — an estimated $5.45M sold.

Qube Research & Technologies (QRT) first reported a position in TWST in Q1 2021 and held it in 13 quarters. The position peaked at $16.1M in Q3 2025. 281 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Twist Bioscience position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 171,972 Twist Bioscience shares in Q1 2026, an estimated $5.45M.
  • Qube Research & Technologies (QRT) first reported a position in Twist Bioscience in Q1 2021 and held it in 13 quarters.
  • Qube Research & Technologies (QRT)'s Twist Bioscience position peaked at $16.1M in Q3 2025.
  • 281 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.